Literature DB >> 18338788

Anger and assaultiveness of male forensic patients with developmental disabilities: links to volatile parents.

Raymond W Novaco1, John L Taylor.   

Abstract

This study with 107 male forensic patients with developmental disabilities investigated whether exposure to parental anger and aggression was related to anger and assaultiveness in a hospital, controlling for background variables. Patient anger and aggression were assessed by self-report, staff-ratings, and archival records. Exposure to parental anger/aggression, assessed by a clinical interview, was significantly related to patient self-reported anger, staff-rated anger and aggression, and physical assaults in hospital, controlling for age, intelligence quotient, length of hospital stay, violent offense history, and childhood physical abuse. Results are consonant with previous findings concerning detrimental effects of witnessing parental violence and with the theory on acquisition of cognitive scripts for aggression. Implications for clinical assessment and cognitive restructuring in anger treatment are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18338788     DOI: 10.1002/ab.20254

Source DB:  PubMed          Journal:  Aggress Behav        ISSN: 0096-140X            Impact factor:   2.917


  3 in total

1.  Characteristics of assaultive psychiatric patients: 20-year analysis of the Assaultive Staff Action Program (ASAP).

Authors:  Raymond B Flannery; Ellen Farley; Timothy Tierney; Andrew P Walker
Journal:  Psychiatr Q       Date:  2011-03

2.  Importance of gender and attitudes about violence in the relationship between exposure to interparental violence and the perpetration of teen dating violence.

Authors:  Jeff R Temple; Ryan C Shorey; Susan R Tortolero; David A Wolfe; Gregory L Stuart
Journal:  Child Abuse Negl       Date:  2013-03-13

Review 3.  Individuals with developmental delay and problematic sexual behaviors.

Authors:  William R Lindsay; Amanda M Michie
Journal:  Curr Psychiatry Rep       Date:  2013-04       Impact factor: 5.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.